Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon M Laws

Showing results (121-130 of 190) with videos related to

Pageof 19
Sort By:
Communications Medicine|February 27, 2025
Alzheimer's disease biological PET staging using plasma p217+tauAzadeh Feizpour, Vincent Doré, Natasha Krishnadas, et al.
Alzheimer'S Research & Therapy|April 11, 2015
Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohortVeer B Gupta, Andrea C Wilson, Samantha Burnham, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 2, 2018
Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older AdultsChrista Dang, Karra D Harrington, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD|February 25, 2017
APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older AdultsSimone Hollands, Yen Ying Lim, Simon M Laws, et al.
International Journal of Molecular Sciences|July 27, 2022
Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer's DiseaseYihan Li, Xin Huang, Christopher Fowler, et al.
Scientific Reports|December 11, 2021
Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNIRosita Shishegar, Timothy Cox, David Rolls, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2023
Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adultsMichael G Slee, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Hormones and Behavior|March 14, 2021
Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognitionSherilyn Tan, Tenielle Porter, Romola S Bucks, et al.
International Psychogeriatrics|October 3, 2018
Subjective memory complaints predict baseline but not future cognitive function over three years: results from the Western Australia Memory StudyHamid R Sohrabi, Michael Weinborn, Christoph Laske, et al.
Brain Communications|September 4, 2024
Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adultsAnja Soldan, Jiangxia Wang, Corinne Pettigrew, et al.
Pageof 19

Showing results (121-130 of 190) with videos related to

Sort By:
Pageof 19
Communications Medicine|February 27, 2025
Alzheimer's disease biological PET staging using plasma p217+tauAzadeh Feizpour, Vincent Doré, Natasha Krishnadas, et al.
Alzheimer'S Research & Therapy|April 11, 2015
Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohortVeer B Gupta, Andrea C Wilson, Samantha Burnham, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 2, 2018
Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older AdultsChrista Dang, Karra D Harrington, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD|February 25, 2017
APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older AdultsSimone Hollands, Yen Ying Lim, Simon M Laws, et al.
International Journal of Molecular Sciences|July 27, 2022
Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer's DiseaseYihan Li, Xin Huang, Christopher Fowler, et al.
Scientific Reports|December 11, 2021
Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNIRosita Shishegar, Timothy Cox, David Rolls, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2023
Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adultsMichael G Slee, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Hormones and Behavior|March 14, 2021
Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognitionSherilyn Tan, Tenielle Porter, Romola S Bucks, et al.
International Psychogeriatrics|October 3, 2018
Subjective memory complaints predict baseline but not future cognitive function over three years: results from the Western Australia Memory StudyHamid R Sohrabi, Michael Weinborn, Christoph Laske, et al.
Brain Communications|September 4, 2024
Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adultsAnja Soldan, Jiangxia Wang, Corinne Pettigrew, et al.
Pageof 19